BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• Deals

  Aflac Incorporated Announces $20 Million Minority Equity Investment in Singapore Life Pte. Ltd.; American Family Life Assurance Company of Columbus to Enter into Reinsurance Agreement with Singapore Life Pte. Ltd.

  Aflac Incorporated announced today that it has made a $20 million minority equity investment in Singapore Life Pte. Ltd., a digitally-focused life insurance company based in Singapore.

  December 31, 2018

   · 

  7 min read
• Drug Development

  Precigen to Debut Portfolio at Investor Event during the 37th Annual J.P. Morgan Healthcare Conference

  Company to provide first-look at preclinical and clinical portfolio

  December 31, 2018

   · 

  2 min read
• Job Trends

  Artificial Intelligence Capabilities and Commercial Applications Will Continue to Progress Rapidly in 2019, But Growth Will Also Bring Growing Pains, According to Tractica

  New White Paper Identifies 10 Predictions for AI in 2019, Including Commercialization of New Technologies, Growth of New Application Markets, Changes in Hardware Architectures and Infrastructure, and Evolution of Business Models and Public Policy

  December 31, 2018

   · 

  2 min read
• Job Trends

  Lipocine Announces Successful Ex Vivo Conversion Assessment of TLANDO™

  Lipocine, Inc. today announced completion of a definitive phlebotomy study (“Phlebotomy Study”) to assess the extent, if any, of clinically meaningful ex vivo conversion of testosterone undecanoate (“TU”) to testosterone (“T”) in serum blood collection tubes.

  December 31, 2018

   · 

  4 min read